Gossamer Bio Inc (NASDAQ:GOSS) shares, rose in value on Wednesday, February 12, with the stock price up by 2.42% to the previous day’s close as strong demand from buyers drove the stock to $1.27.
Actively observing the price movement in the last trading, the stock closed the session at $1.24, falling within a range of $1.225 and $1.37. The value of beta (5-year monthly) was 1.96. Referring to stock’s 52-week performance, its high was $1.60, and the low was $0.50. On the whole, GOSS has fluctuated by 37.61% over the past month.
With the market capitalization of Gossamer Bio Inc currently standing at about $287.79 million, investors are eagerly awaiting this quarter’s results, scheduled for in March.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 7.02M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that GOSS’s technical picture suggests that short-term indicators denote the stock is a 100% Buy on average. However, medium-term indicators have put the stock in the category of 50% Buy while long-term indicators on average have been pointing out that it is a 100% Buy.
The stock’s technical analysis shows that the price of GOSS currently trading nearly 25.20% and 37.94% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 70.62, while the 7-day volatility ratio is showing 11.89% which for the 30-day chart, stands at 10.06%. Furthermore, Gossamer Bio Inc (GOSS)’s beta value is 1.90, and its average true range (ATR) is 0.10.
A comparison of Gossamer Bio Inc (GOSS) with its peers suggests the former has fared considerably weaker in the market. GOSS showed an intraday change of 2.42% in last session, and over the past year, it grew by 45.98%%.
Data on historical trading for Gossamer Bio Inc (NASDAQ:GOSS) indicates that the trading volumes over the past 10 days have averaged 1.37 and over the past 3 months, they’ve averaged 1.49 million. According to company’s latest data on outstanding shares, there are 226.60 million shares outstanding.
Nearly 23.20% of Gossamer Bio Inc’s shares belong to company insiders and institutional investors own 61.13% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 5.81 million shares as on 2025-01-31, resulting in a short ratio of 6.09. According to the data, the short interest in Gossamer Bio Inc (GOSS) stood at 264.00 of shares outstanding as of 2025-01-31; the number of short shares registered in 2024-12-31 reached 6.12 million. The stock has risen by 40.39% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the GOSS stock heading into the next quarter.
